Mini review: Prevention of mother–child transmission of HIV: 25 years of continuous progress toward the eradication of pediatric AIDS?

References

• Oleske J, Minnefor A, Cooper R Jr, et al. Immune deficiency syndrome in children. JAMA. 1983;249:2345–2349.
   PubMed Web of Science ®Google Scholar
• Wedi CO, Kirtley S, Hopewell S, et al. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV. 2016;3:e33–e48.
   PubMed Web of Science ®Google Scholar
• Blanche S, Rouzioux C, Moscato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV infection in newborns French Collaborative Study Group. N Engl J Med. 1989;320:1643–1648.
   PubMed Web of Science ®Google Scholar
• Johnson EL, Chakraborty R. HIV-1 at the placenta: immune correlates of protection and infection. Curr Opin Infect Dis. 2016;29:248–255.
   PubMed Web of Science ®Google Scholar
• Mwanyumba F, Gaillard P, Inion I, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr. 2002;29:262–269.
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Sungkarat S, Shaffer N, et al. Placental abnormalities associated with human immunodeficiency virus type 1 infection and perinatal transmission in Bangkok, Thailand. J Infect Dis. 2000;182:1652–1657.
   PubMed Web of Science ®Google Scholar
• Kalk E, Schubert P, Bettinger JA, et al. Placental pathology in HIV infection at term: a comparison with HIV-uninfected women. Trop Med Int Health. 2017;22:604–613.
   PubMed Web of Science ®Google Scholar
• Sheikh AU, Polliotti BM, Miller RK. Human immunodeficiency virus infection: in situ polymerase chain reaction localization in human placentas after in utero and in vitro infection. Am J Obstet Gynecol. 2000;182:207–213.
   PubMed Web of Science ®Google Scholar
• Johnson EL, Chakraborty R. Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines. Retrovirology. 2012;9:101.
   PubMed Web of Science ®Google Scholar
• Permar SR, Fong Y, Vandergrift N, et al. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. J Clin Invest. 2015;125:2702–2706.
   PubMed Web of Science ®Google Scholar
• McLaren PJ, Carrington M. The impact of host genetic variation on infection with HIV-1. Nat Immunol. 2015;16:577–583.
   PubMed Web of Science ®Google Scholar
• Mackelprang RD, John-Stewart G, Carrington M, et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis. 2008;197:1156–1161.
   PubMed Web of Science ®Google Scholar
• Burgard M, Blanche S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr. 2012;160:60–66.
   PubMed Web of Science ®Google Scholar
• Van de Perre P, Rubbo PA, Viljoen J, et al. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med. 2012;4:143sr3.
   PubMed Web of Science ®Google Scholar
• Mock PA, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS. 1999;13:407–414.
   PubMed Web of Science ®Google Scholar
• Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Paediatric AIDS Clinical Trials Group Protocol 076 study group. N Engl J Med. 1994;331:1173–1180.
   PubMed Web of Science ®Google Scholar
• Luzuriaga K, Mofenson LM. Challenges in the elimination of pediatric HIV-1 infection. N Engl J Med. 2016;374:761–770.
   PubMed Web of Science ®Google Scholar
• Broder S. Twenty-five years of translational medicine in antiretroviral therapy: promises to keep. Sci Transl Med. 2010;2:39ps33.
   PubMed Web of Science ®Google Scholar
• Mandelbrot L, Tubiana R, Le Chenadec J, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;61:1715–1725.
   PubMed Web of Science ®Google Scholar
• WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. [Internet]. Geneva: World Health Organization; 2016.
   Google Scholar
• Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. [accessed 2019 Dec 14]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf.
   Google Scholar
• Bailey H, Zash R, Rasi V, et al. HIV treatment in pregnancy. Lancet HIV. 2018;5:e457–e467.
   PubMed Web of Science ®Google Scholar
• Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 2018;379:979–981.
   PubMed Web of Science ®Google Scholar
• Beste S, Essajee S, Siberry G, et al. Optimal antiretroviral prophylaxis in infants at high risk of acquiring HIV: a systematic review. Pediatr Infect Dis J. 2018;37:169–175.
   PubMed Web of Science ®Google Scholar
• Drake AL, Wagner A, Richardson B, et al. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001608.
   PubMed Web of Science ®Google Scholar
• De Cock KM, Fowler M, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–1182.
   PubMed Web of Science ®Google Scholar
• Veroniki AA, Antony J, Straus SE, et al. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: systematic review and network meta-analysis including different study designs. PLoS One. 2018;13:e0198447.
   PubMed Web of Science ®Google Scholar
• Aizire J, Fowler MG, Coovadia HM. Operational issues and barriers to implementation of prevention of mother-to-child transmission of HIV (PMTCT) interventions in sub-Saharan Africa. Curr HIV Res. 2013;11:144–159.
   PubMed Web of Science ®Google Scholar
• Vrazo AC, Firth J, Amzel A, et al. Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review. Trop Med Int Health. 2018;23:136–148.
   PubMed Web of Science ®Google Scholar
• [accessed 2019 Dec 14]. Available from: http://www.unaids.org/sites/default/files/media_asset/JC2774_2015ProgressReport_GlobalPlan_en.pdf
   Google Scholar
• Karnon J, Orji N. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses. Health Policy Plan. 2016;31:1133–1141.
   PubMed Web of Science ®Google Scholar
• Waitt C, Low N, Van de Perre P, et al. Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings. Lancet HIV. 2018;5:e531–e536.
   PubMed Web of Science ®Google Scholar
• Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis. 2016;16:e92–e107.
   PubMedGoogle Scholar
• Jensen SKG, Berens AE, Nelson CA 3rd. Effects of poverty on interacting biological systems underlying child development. Lancet Child Adolesc Health. 2017;1:225–239.
   PubMedGoogle Scholar
• Viteri OA, Soto EE, Bahado-Singh RO, et al. Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review. Am J Perinatol. 2015;32:405–416.
   PubMed Web of Science ®Google Scholar
• Afran L, Garcia Knight M, Nduati E, et al. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176:11–22.
   PubMed Web of Science ®Google Scholar
• Sibiude J, Warszawski J, Blanche S. Tolerance of the newborn to antiretroviral drug exposure in utero. Expert Opin Drug Saf. 2015;14:643–654.
   PubMed Web of Science ®Google Scholar
• Xiao PL, Zhou YB, Chen Y, et al. Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth. 2015;15:246.
   PubMed Web of Science ®Google Scholar
• Saleska JL, Turner AN, Maierhofer C, et al. Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in low- and middle-income countries: a systematic review. J Acquir Immune Defic Syndr. 2018;79:1–9.
   PubMed Web of Science ®Google Scholar
• Sibiude J, Mandelbrot L, Blanche S, et al. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11). PLoS Med. 2014;11:e1001635.
   PubMed Web of Science ®Google Scholar
• Else LJ, Taylor S, Back DJ, et al. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid). Antivir Ther. 2011;16:1139–1147.
   PubMed Web of Science ®Google Scholar
• Blanche S, Tardieu M, Benhammou V, et al. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS. 2006;20:1685–1690.
   PubMed Web of Science ®Google Scholar
• Brennan AT, Bonawitz R, Gill CJ, et al. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS. 2016;30:2351–2360.
   PubMed Web of Science ®Google Scholar
• Jones CE, Naidoo S, De Beer C, et al. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305:576–584.
   PubMed Web of Science ®Google Scholar
• Hleyhel M, Goujon S, Delteil C, et al. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016;30:1245–1256.
   PubMed Web of Science ®Google Scholar
• André-Schmutz I, Dal-Cortivo L, Six E, et al. Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination. J Infect Dis. 2013;208:235–243.
   PubMed Web of Science ®Google Scholar